Mexiletine Hydrochloride

CHEMBL1200606 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
215.7 g/mol
LogP
Phase
4

This is the hydrochloride salt form of mexiletine; see mexiletine for full prescribing information.

Molekularmasse

215,7200 g/mol

TPSA

35,30 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1cccc(C)c1OCC(C)N.Cl

InChI

InChI=1S/C11H17NO.ClH/c1-8-5-4-6-9(2)11(8)13-7-10(3)12;/h4-6,10H,7,12H2,1-3H3;1H

Molecular Formula

C11H18ClNO

HBD / HBA

2 / 2

Rotierbare Bindungen

3

Schwere Atome

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

This is the hydrochloride salt form of mexiletine; see mexiletine for full prescribing information.

Yes, Mexiletine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200606. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 21467. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.